Defining the Epidemiology and Burden of Severe Respiratory Syncytial Virus Infection Among Infants and Children in Western Countries

Overview of attention for article published in Infectious Diseases and Therapy, August 2016

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#25 of 835)
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

So far, Altmetric has seen 8 news stories from 8 outlets.

Nirsevimab is the first investigational long-acting antibody designed for all infants to help protect against respiratory…

Credit: Shutterstock Australia is opening up, people are mixing and mingling, and schools are back.

Australia is opening up, people are mixing and mingling, and schools are back. But there's a downside.

– By Natasha Yates, Assistant Professor, General Practice, Bond University Australia is opening up, people are mixing and…

Australia is opening up, people are mixing and mingling, and schools are back. But there’s a downside.

Australia is opening up, people are mixing and mingling, and schools are back. But there’s a downside.

Australia is opening up, people are mixing and mingling, and schools are back. But there’s a downside.

Australia is opening up, people are mixing and mingling, and schools are back. But there’s a downside.